Holen Sie sich die Stockscreener-App
1.11
6.72%
-0.08
Vorhandelsmarkt:
1.13
0.02
+1.80%
Standard Biotools Inc Aktie (LAB) Neueste Nachrichten
Standard BioTools Inc.'s (NASDAQ:LAB) Popularity With Investors Under Threat As Stock Sinks 27% - simplywall.st
Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - GlobeNewswire
Swing Trade: Will BayFirst Financial Corp benefit from geopolitical trends2025 Valuation Update & Weekly High Conviction Ideas - baoquankhu1.vn
Market Outlook: Can Standard BioTools Inc stock outperform in a bear market2025 Top Gainers & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Standard BioTools Strengthens Balance Sheet with Major Divestiture - AD HOC NEWS
Aug Patterns: Is Standard BioTools Inc impacted by rising ratesJuly 2025 Technicals & Weekly Market Pulse Alerts - baoquankhu1.vn
Market Pulse: Will Standard BioTools Inc stock recover after earnings2025 Momentum Check & Safe Entry Point Identification - baoquankhu1.vn
Illumina completes acquisition of SomaLogic - marketscreener.com
Weekly Earnings: How volatile is Standard BioTools Inc stockJuly 2025 Chart Watch & Daily Stock Momentum Reports - baoquankhu1.vn
Standard BioTools completes sale of SomaLogic to Illumina for $350 million - Investing.com Nigeria
Standard BioTools Inc. (LAB) Stock Analysis: Navigating Challenges with a 9.93% Potential Upside - DirectorsTalk Interviews
Standard BioTools (LAB) Concludes Sale of SomaLogic for $425 Mil - GuruFocus
Standard BioTools Completes Major Proteomics Business Divestiture - TipRanks
Standard BioTools Completes Sale of SomaLogic to Illumina - citybiz
Standard BioTools Inc. Completes $350 Million Sale of SomaLogic to Illumina, Enhancing Financial Position for Growth Strategy - Quiver Quantitative
Illumina (NASDAQ: ILMN) completes $350M SomaLogic proteomics deal - Stock Titan
Here's Why We're Not At All Concerned With Standard BioTools' (NASDAQ:LAB) Cash Burn Situation - simplywall.st
Aug Reactions: Is Paramount Global stock risky to hold now2025 Technical Patterns & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Standard BioTools (NASDAQ:LAB) versus Clover Health Investments (NASDAQ:CLOV) Critical Review - Defense World
Chipmakers Recap: Can Standard BioTools Inc stock double in the next yearJuly 2025 Highlights & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Aug Outlook: Will Standard BioTools Inc stock recover after earningsPortfolio Growth Summary & Fast Entry High Yield Tips - baoquankhu1.vn
Standard BioTools (NASDAQ:LAB) shareholders have endured a 76% loss from investing in the stock five years ago - Yahoo Finance
Death Cross: Is Sunshine Biopharma Incs ROE strong enoughEarnings Growth Report & Stock Portfolio Risk Management - baoquankhu1.vn
The Truth About SomaLogic Inc: Is This Quiet Biotech About To Blow Up Or Fade Out? - AD HOC NEWS
Sumitomo Mitsui Trust Group Inc. Sells 773,708 Shares of Standard BioTools Inc. $LAB - MarketBeat
SomaLogic Urges Stockholders to Maximize Value of Their Investment by Voting "FOR" Pending Merger with Standard BioTools - Intellectia AI
Standard BioTools Inc. (LAB) Stock Analysis: Navigating a Challenging Market with Innovative Technologies - DirectorsTalk Interviews
Sentiment Recap: Why Standard BioTools Inc stock could rally in 20252025 Growth vs Value & Trade Opportunity Analysis - Bộ Nội Vụ
Standard BioTools (NASDAQ:LAB) Trading 5.6% HigherStill a Buy? - MarketBeat
Illumina Announces Preliminary Unaudited Financial Results for Q4 and Fiscal Year 2025 - TradingView
Why Standard BioTools Inc. stock could outperform in 2025Market Growth Summary & AI Powered Market Trend Analysis - ulpravda.ru
Will Standard BioTools Inc. stock benefit from green energy trendsPortfolio Risk Report & Reliable Intraday Trade Alerts - Улправда
User | woonsocketcall.comStandard BioTools Inc.Common Stock (Nasdaq:LAB) Stock Quote - FinancialContent
Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue - Sahm
Can Standard BioTools Inc. stock maintain operating marginsLayoff News & Expert-Curated Trade Recommendations - Улправда
Will Standard BioTools Inc. (FLB) stock rise with strong economyJuly 2025 Catalysts & Low Risk High Reward Ideas - Улправда
Is Standard BioTools Inc. stock a buy before product launchesMarket Risk Summary & High Accuracy Investment Signals - ulpravda.ru
Standard BioTools (NASDAQ:LAB) Shares Gap UpShould You Buy? - MarketBeat
Standard BioTools Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2025 - marketscreener.com
Standard BioTools Reports Preliminary Q4, Full-Year Revenue - Nasdaq
Standard BioTools (NASDAQ:LAB) & Hinge Health (NYSE:HNGE) Critical Contrast - Defense World
What analysts say about Standard BioTools Inc stockExit Strategy Tips & Investment Portfolio Recommendations - earlytimes.in
User | theeveningleader.comStandard BioTools Inc.Common Stock (Nasdaq:LAB) Stock Quote - markets.financialcontent.com
Further weakness as Standard BioTools (NASDAQ:LAB) drops 15% this week, taking five-year losses to 80% - simplywall.st
Standard BioTools: Outlook Still Murky (NASDAQ:LAB) - Seeking Alpha
Institutional owners may consider drastic measures as Standard BioTools Inc.'s (NASDAQ:LAB) recent US$96m drop adds to long-term losses - Yahoo Finance
Standard BioTools (NASDAQ:LAB) Stock Price Down 6.1% – Here’s Why - Defense World
Standard BioTools (NASDAQ:LAB) Stock Price Down 6.1%What's Next? - MarketBeat
What Standard BioTools Inc.'s (NASDAQ:LAB) 28% Share Price Gain Is Not Telling You - 富途牛牛
Standard BioTools (NASDAQ:LAB) Stock Price Down 3.9% – What’s Next? - Defense World
With Standard BioTools Stock Surging, Have You Considered The Downside? - Trefis
Can Standard BioTools Inc. stock sustain market leadershipWeekly Profit Summary & Detailed Earnings Play Alerts - Улправда
0.45%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):